Background {#Sec1}
==========

Diarrhea is one of the most common diseases in children in developed and developing countries. It has been documented that there are about two billion cases of diarrheal disease worldwide every year and 1.9 million children younger than 5 years of age hospitalized due to diarrhea each year (Farthing et al. [@CR23]). It has also been recorded that more than 5000 children are dying every day as a result of diarrheal diseases (Farthing et al. [@CR23]). One of the most prevalent cause of diarrhea in children less than 5 years old is *Clostridium difficile* (*C. difficile*) (Wilson [@CR22]; Koletzko and Osterrieder [@CR10]). *C. difficile* is a spore-forming, anaerobic, gram-positive bacillus an etiologic agent of nosocomial diarrhea and pseudomembranous colitis. Disease is mainly occurred in children who have been treated with long term antibiotics (Brown et al. [@CR4]; Min Cho et al. [@CR17]).

Changes in the epidemiology of *C. difficile* infections in the pediatric population is a serious concern. However, benign neonatal colonization with toxigenic *C. difficile* is a well-documented phenomenon but recent studies have suggested an increased incidence of *C. difficile* associated diarrhea (CDAD) in children (Cohen et al. [@CR5]; Gleizes et al. [@CR6]). Previous investigation which was conducted on 22 hospitals in the United States reported an increased prevalence of CDAD in children (increased by 53 % from 2001 to 2006, with 26 % of patients with CDAD ≤1 year of age) (Cohen et al. [@CR5]).

Polymerase chain reaction (PCR)-based ribotyping of *C. difficile* in clinical samples is a good approach to identify the novel aspects in the epidemiology of diarrhea caused by this bacterium in children (Arvand et al. [@CR1]; Krutova et al. [@CR11]). High prevalence of *C. difficile* ribotype 027 (RT027) in the clinical samples of pediatric patients have been reported in various studies (Arvand et al. [@CR1]; Krutova et al. [@CR11]; Oleastro et al. [@CR18]). Diarrheal disease caused by this ribotype of the *C. difficile* is more severe, with higher rates of morbidity and mortality and more virulent (Arvand et al. [@CR1]; Krutova et al. [@CR11]; Oleastro et al. [@CR18]).

According to the high potential of *C. difficile* in causing infection, diarrhea and various complications in pediatrics, typing of this bacterium is essential to understand the exact epidemiology of outbreaks, identify any possible incidence of cross infection and to set up surveillance programs to monitor virulent strain emergence and hospital reservoirs. However, few studies have been addressed in this field in Iran. Therefore, the present study was carried out in order to study the prevalence of *C. difficile* and its ribotypes in Iranian pediatric patients suffered from nosocomial diarrhea.

Results and discussion {#Sec2}
======================

Between zero to three antibiotics were used by patients with average 1.42 ± 0.68. Four patients did not take any antibiotic. Fifty-seven patients received one, thirty-two received two and seven received three types of antibiotics. There were no antibiotic usage in the control group. Gentamycin, ceftriaxone, ampicillin, erythromycin, clindamycin and vancomycin were used in the pediatric patients of this study. The treatment periods by antibiotics were different according to the type of infection. The average age of patients was 11.8 ± 15.3 months (range 6--60 months), and 47 % were female. The average weight of patients was 9 ± 2.7 kg. Frequency of *C. defficile* based on each sex and age groups is shown in Table [1](#Tab1){ref-type="table"}. Chi Square test didn't show any significant difference for the distribution of *C. defficile* based on sex and age group of children. The most commonly used antibiotic agent was ceftriaxone (93 %). There were no significant relation between positive results with antibiotic treatment.Table 1Prevalence of *C. defficile* based on sex and age groupsGroups of childrenVariableGroupPositiveNegativeTotalP valueNumberPercentNumberPercentNumberPercentPatientsSexGirl2348.92451.1471000.564Boy2954.72445.353100Age6--12 months30503050601000.81413--24 months1657.11242.928100\>24 months65065012100HealthySexGirl23.35896.6601000.225Boy45.716694.270100Age6--12 months----581005810013--24 months12.53997.5401000.198\>24 months515.62784.3321000.312

Electrophoresis of PCR products revealed 5--6 fragments with 260--600 bp(s) length which showed the distribution of *C. difficile* ribotypes. From 100 examined samples, 52 (52 %) were positive for *C. difficile*. Total prevalence of *C. difficile* in girls and boys patients were 48.9 and 54.7 %, respectively. Thirteen to twenty-four month age children had the highest prevalence of *C. difficile*. Of 130 fecal samples of healthy children, 6 samples (4.61 %), were positive for *C. difficile*. Boys had the higher prevalence of *C. difficile* than girls. Older than 24 months healthy children had the highest prevalence of *C. difficile* (15.6 %). There were statistically significant differences (p \< 0.05) for the prevalence of the *C. difficile* between healthy and sick groups. The most commonly detected ribotypes in the *C. difficile* isolates of hospitalized children were RT027 (11.52 %), RT01 (9.61 %) and RT013 (7.68 %) (Table [2](#Tab2){ref-type="table"}). Totally, the ribotypes of the 13.44 % of *C. difficile* isolates of hospitalized children and all of the healthy children were not recognized.Table 2Distribution of ribotypes of *C. difficile* in the stool specimens of hospitalized and healthy pediatric of IranRibotypesTotal distribution in hospitalized childrenTotal distribution in healthy childrenNumberPercent (%)NumberPercent (%)R159.61----R723.84----R823.84----R1235.76----R1347.68----R1535.76----R1835.76----R27611.52----R2823.84----R2935.76----R3135.76----R3211.92----R8111.92----R8211.92----R8323.84----R8611.92----R8723.84----R8811.92----^a^713.446100Total521006100^a^Unknown ribotype

*C. difficile* was the most common agent observed in 52 % of episodes associated with nosocomial diarrhea in this pediatric population. The prevalence of *C. difficile* nosocomial diarrhea was varied in different studies, but there is limit studies in this field in Iran. Sadeghifard et al. ([@CR19]) were analyzed a total of 942 stool samples from Iranian patients with nosocomial diarrhea. They showed that 57 samples (6.1 %) were positive for toxigenic *C. difficile* (Sadeghifard et al. [@CR19]). One possible difference between our results and the results of Sadeghifard et al. ([@CR19]) was the fact that they found significant differences (p \< 0.05) between the rate of isolated toxigenic *C. difficile* and age of patients (Sadeghifard et al. [@CR19]). Miller et al. ([@CR16]) assessed the healthcare burden, morbidity, and mortality of nosocomial *C. difficile*-associated diarrhea (N-CDAD) in Canadian hospitals. They found that 371 out of 2062 tested samples (18 %) were positive for *C. difficile* and 269 strains of total 371 positive isolates (13 %) met the case definition for nosocomial CDAD (Miller et al. [@CR16]). In the survey which was conducted by Langley et al. ([@CR13]), *C. difficile* (39 of 122; 32 %) was one of the most common pathogens in nosocomial diarrhea episodes (Langley et al. [@CR13]) which was similar to our findings. In a study carried out by Gursoy et al. ([@CR7]), the total prevalence of *C. difficile* was 27.7 % and the most commonly used antibiotic was clindamycin (Gursoy et al. [@CR7]).

Direct detection of *C. difficile* toxin genes in stool samples by real-time PCR has a sensitivity superior than stool culture EIAs and performance comparable to that of real-time PCR assay of cultured isolates. Luna et al. ([@CR14]) found that the sensitivities of stool real-time PCR and stool EIA were 95 and 35 %, respectively, with a specificity of 100 % for both methods (Luna et al. [@CR14]).

In our study, majority of patients with *C. difficile* infections received antibiotics. One of the most frequent complications of antibiotic therapy is diarrheal syndrome, which may be related both to the direct toxic effects of antibiotics on the gastrointestinal tract, and the activation of conditionally pathogenic intestinal flora. Therefore, particular attention should perform on the problem of *C. difficile* infections, which may be the consequence of the development of pseudomembranous colitis in both children and adults (Zakharova et al. [@CR24]).

Antimicrobial agents are the most frequently prescribed medicines in children because of acute infectious diarrhea. The previous study which was conducted on the pediatric patients of same hospital represented that the total prescription of antibiotics in an irregular and inappropriate manner was 37 % (Khoshdel and Panahandeh [@CR9]). Therefore, it is not surprising that the prevalence of *C. difficile* in the pediatric patients of our study was 52 %. Types of antibiotics used for treatment of cases of diarrhea can influence on the prevalence of *C. difficile*. It is because of the medical practitioners do not use inexpensive and easy assays like the disk diffusion method for antibiotic prescription. In fact, the experience of medical practitioners in the treatment of previous cases of diseases, is their main reason for antibiotic prescription. It is clear that the previous experiences of practitioners are not sufficient for treatment of the novel cases of diseases like diarrhea. Therefore, prescription of antibiotics in a highly irregular manner and without accordance to the results of disk diffusion method, caused occurrence of antibiotic resistance in bacteria like *C. difficile*. Therefore, presence of the resistant strains of this bacterium will increase. Low prevalence of this bacterium in healthy children which didn't receive any antibiotics has indirectly confirmed the relationship between antibiotic prescription and occurrence of *C. difficile* infections.

Another part of our investigation has focused on the determination of ribotypes of *C. difficle*. Result showed that the most commonly detected ribotype in the *C. difficile* isolates of our investigation was RT027. Prior to 2003 year, only a handful of these strains were isolated in the United Kingdom, whereas currently most typed isolates are RT027. This is also mirrored in Canada, where RT027 strains were undetected in 2000, but reached 75.2 % of all PCR-ribotype strains in 2003 (MacCannell et al. [@CR15]). Kuijper et al. ([@CR12]) reported that the RT027 of the *C. difficile* was the most commonly detected ribotypes in the cases of severe complicated diarrhea. High prevalence of the RT027 strains of *C. difficile* have been reported in majority of European countries such as Germany, France, Belgium, Ireland, Finland, Poland, Spain, Hungary, the Netherlands, Switzerland, Luxembourg and also the United Kingdom (Kuijper et al. [@CR12]). Oleastro et al. ([@CR18]) reported that 72.72 % of the *C. difficile* isolates of pediatrics in Portugal were positive for the RT027 which was entirely high.

Methods {#Sec3}
=======

Ethical considerations {#Sec4}
----------------------

This research project has been approved by the ethical committee of Shahrekord University of Medical Sciences, Iran. Informed consent was obtained from pediatrics or their parents.

Samples collection and bacterial isolation {#Sec5}
------------------------------------------

This cross-sectional study was conducted from December 2013 to May 2014. The studied population comprised all patients, aged 6--60 months, who had been hospitalized in the pediatric ward of Hospitals because of diseases other than diarrhea such as urinary tract infection, bacterial pneumonia, acute respiratory illness and skin infections. Fecal specimens were collected from 100 children with clinical signs of nosocomial diarrhea admitted in the hospitals and health centers of south west of Iran. Nosocomial diarrhea was defined as diarrhea occurring more than 72 h after admission to hospital for non-diarrheal causes. The fecal samples were transported daily to the Cellular and Molecular Research Center, Shahrekord University of Medical Sciences in refrigerated boxes using the Cary-Blair transport (Para-Pak™ C&S transport media; Meridian Diagnostics, Cincinnati, OH, USA) transitional media. The fecal samples of 130 healthy children with similar criteria (male and female, aged 6--60 months) were also collected for the control group.

Five gram of each sample was transferred to 20 mL of *C. difficile* broth (CDB; Oxoid SR0048) containing 40 g/l proteose peptone, 5.0 g/l disodium hydrogen phosphate, 0.1 g/l magnesium sulphate, 2.0 g/l sodium chloride, 6.0 g/l fructose and 1.0 g/l sodium taurocholate supplement with *C. difficile* selective supplement (Oxoid, UK, Code: SR0173) and 5 % (v/v) defibrinated sheep blood. After incubation at 37 °C for 2 days under anaerobic conditions, 2 mL of the enrichment broth was added to 2 mL of 96 % ethanol in a centrifuge tube and homogenized for 50 min on a shaker at room temperature. After centrifugation (3800×*g* for 10 min), a loopful of the sediment was streaked onto cycloserine cefoxitin fructose agar (CCFA) containing sodium taurocholate. All plates were incubated in an anaerobic chamber (Don Whitley Scientific Ltd., Shipley West Yorkshire, UK) at 37 °C for 48 h. Colonies of *C. difficile* were identified on the basis of their characteristic colony morphology (yellow, ground glass appearance), Gram staining, odour (horse dung smell), their chartreuse fluorescence under long-wave UV light (\~360 nm) and [l]{.smallcaps}-proline aminopeptidase test (Harvey et al. [@CR8]).

Ribotyping of *C. difficile* {#Sec6}
----------------------------

Genomic DNA was extracted from typical colonies of *C. difficile* using genomic DNA extraction Kit (Fermentase, Germany) according to the manufacturer's recommendation. The isolated DNA was quantified by spectrophotometric measurement at a wave length of 260 nm according to the method described by Sambrook and Russell ([@CR20]). The extracted DNA of each specimen was kept frozen at −20 °C until used. Colonies of *C. difficile* were approved another one using the real-time PCR method described by Bélanger et al. ([@CR2]).

PCR ribotyping {#Sec7}
--------------

Ribotyping was done in the Biotechnology Research Center of the Islamic Azad University of Shahrekord Branch, Iran. PCR technique was used to study the distribution of ribotypes of *C. difficile*. The oligonucleotide primers p3-F: 5′-CTGGGGTGAAGTCGTAACAAGG-3′ (position 1445--1466 of the 16S rRNA gene) and p5-R: 5′-GCGCCCTTTGTAGCTTGACC-3′ (position 20--1 of the 23S rRNA gene) described by Stubbs et al. ([@CR21]) were used for gene amplification. *C. difficile* 027/NAP1/BI strain was used as a positive control. A negative-DNA control was performed by adding 1 μL of sterile ultrapure deionized water. For investigation of ribotypes of *C. difficile* the specimens were amplified in a Gradient Palm Cycler (Corbett Research, Australia) and PCR was performed in a total volume of 25 μL including 0.5 ml tubes containing 1 μg of genomic DNA, 1 μM of each primer, 2 mM MgCl~2~, 200 Μm dNTP, 2.5 μL of 10× PCR buffer and 1 unit of Taq DNA polymerase (Fermentas, Germany). PCR cycles consisted of an initial denaturation step (95 °C for 5 min) followed by 30 amplification cycles (denaturation at 94 °C for 1 min, annealing at 62 °C for 1 min, and elongation at 72 °C for 1 min) with a final elongation at 72 °C for 5 min and amplified samples were held at 4 °C.

Analysis of PCR products {#Sec8}
------------------------

The amplified products were detected in 1 % agarose gel electrophoresis. The electrode buffer was TBE \[Tris-base 10.8 g 89 mM, Boric acid 5.5 g 2 mM, EDTA (pH 8.0) 4 ml of 0.5 M EDTA (pH 8.0), combine all components in sufficient H~2~O and stir to dissolve\]. Aliquots of 10 µL of PCR products were applied to the gel. Constant voltage of 80 V for 30 min was used for products separation. The DNA fragment size was compared with a standard molecular weight (100 bp DNA ladder of Fermentas, Germany). After electrophoresis, the amplicons were visualized with ultraviolet light after ethidium bromide (5 μg mL^−1^) staining and photographs were obtained in UVIdoc gel documentation systems (UK).

Ribotyping patterns {#Sec9}
-------------------

Comparison of PCR ribotyping patterns was performed visually. All isolates were typed using the PCR ribotyping method described by Bidet et al. ([@CR3]) and Gel Compare software. Strains with ribotype patterns that differed by at least one band were assigned to different types. Ribotype group was designated by upper and lower-case letters combined with a number.

Statistical analysis {#Sec10}
--------------------

Analysis of data and investigation of ribotypes of *C. difficile* were performed using the SPSS (version 11.5) and Gel Compar software.

Conclusion {#Sec11}
==========

The present study showed a low frequency of nosocomial infection due to *C. difficile* and especially it's RT027. Our work emphasizes the importance of nosocomial infections in pediatric wards which is important as its considerable costs of hospitalization and treatment. A continued ribotype surveillance of *C. difficile* is necessary to monitor changes in the prevalence of strains, to identify the emergence of new strains over time that could affect future vaccine strategies, and to identify any regional differences of ribotype prevalence. Clinician should pay more attention in prescription of antibiotics in the cases of diarrhea especially in children.
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